Clinical Trial Update: Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating plerixafor in multiple myeloma patients previously treated with lenalidomide who planned to undergo autologous stem cell transplant. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Mozobil (plerixafor)

Snippet

Sponsor: Mayo Clinic | Conditions: Multiple Myeloma, Refractory Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2012-07-30